TLP Group’s Alpine Immune Sciences Inc ALPN Stock Holding History

TLP Group’s Portfolio ALPN Stock Details ALPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-2,788	Closed	-$91K	–	397
2016 Q3	$91K	Buy	+2,788	New	+$67.9K	0.1%	222

Other funds holding ALPN

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Tiger Management New York $22.8M AUM 0.71% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TLP Group's ALPN Position: Q4 2016 in Review

TLP Group sold out of Alpine Immune Sciences Inc (ALPN) in Q4 2016, closing a stake of 2,788 shares — an estimated $91K sold.

TLP Group first reported a position in ALPN in Q3 2016 and held it in 1 quarter. The position peaked at $91K in Q3 2016. 38 funds tracked by Wall St. Rank hold ALPN as of Q4 2016.

TLP Group reported no remaining Alpine Immune Sciences Inc position as of Q4 2016 after selling out during the quarter.
TLP Group sold 2,788 Alpine Immune Sciences Inc shares in Q4 2016, an estimated $91K.
TLP Group first reported a position in Alpine Immune Sciences Inc in Q3 2016 and held it in 1 quarter.
TLP Group's Alpine Immune Sciences Inc position peaked at $91K in Q3 2016.
38 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q4 2016.

Based on TLP Group's 13F filing for Q4 2016, filed 2 Feb 2017.